Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DECKER

Showing results (691-700 of 718) with videos related to

Pageof 72
Sort By:
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Cancer Research Communications|May 4, 2026
MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell LymphomaMana Moassefi, Paul A Decker, Gian Marco Conte, et al.
Geroscience|April 22, 2026
Prediction of cognitive test scores: a comparison of brain structure, health, demographic, and cognitive data across adulthoodCamilla Mendl-Heinisch, Nora Bittner, Tatiana Miller, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
Neuro-Oncology Advances|September 8, 2022
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenograftsKendra A Porath, Michael S Regan, Jessica I Griffith, et al.
Molecular Cancer Therapeutics|October 23, 2024
DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway DeficitsSonja Dragojevic, Emily J Smith, Michael S Regan, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
American Journal of Epidemiology|July 12, 2011
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smokingDaniel H Lachance, Ping Yang, Derek R Johnson, et al.
Pageof 72

Showing results (691-700 of 718) with videos related to

Sort By:
Pageof 72
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Cancer Research Communications|May 4, 2026
MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell LymphomaMana Moassefi, Paul A Decker, Gian Marco Conte, et al.
Geroscience|April 22, 2026
Prediction of cognitive test scores: a comparison of brain structure, health, demographic, and cognitive data across adulthoodCamilla Mendl-Heinisch, Nora Bittner, Tatiana Miller, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
Neuro-Oncology Advances|September 8, 2022
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenograftsKendra A Porath, Michael S Regan, Jessica I Griffith, et al.
Molecular Cancer Therapeutics|October 23, 2024
DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway DeficitsSonja Dragojevic, Emily J Smith, Michael S Regan, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
American Journal of Epidemiology|July 12, 2011
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smokingDaniel H Lachance, Ping Yang, Derek R Johnson, et al.
Pageof 72